Biopol Chemicals
February 6, 2026 – February 10, 2026
| Price | ₹102 - ₹108 |
| GMP Rumors * | ₹0 |
|---|---|
| Lot size | 1000 |
| Issue size | ₹31.25 cr |
| Allotment | Feb 11, 2026 |
| Listing | Feb 13, 2026 |
Biopol Chemicals Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 2000 | 216000 | 481 |
| sHNI | 3 | 3000 | 324000 | 122 |
| bHNI | 10 | 10000 | 1080000 | 243 |
Biopol Chemicals Reservation
| Category | Shares Offered | % |
|---|---|---|
| QIB | 686400 | 23.71% |
| HNI | 1094400 | 37.81% |
| INDIVIDUAL | 962400 | 33.25% |
| Market Maker | 151200 | 5.22% |
| Total | 2894400 | 100% |
Biopol Chemicals About
IPO Details
| Total Issue Size | 28,94,400 shares (aggregating up to ₹31.25 Cr) |
| Fresh Issue | 28,94,400 shares (aggregating up to ₹31.25 Cr) |
| Face Value | ₹10/- Per Share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 79,11,000 shares |
| Share Holding Post Issue | 1,08,05,400 shares |
| Reserved for Market Maker | 1,51,200 shares (aggregating up to ₹1.63 Cr) |
| Market Maker | Shreni Shares Ltd. |
Key Performance Indicators (KPI)
| KPI | Dec-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| ROE | 36.32% | 38.10% | 53.91% | 30.79% |
| DEBT/EQUITY | 0.76% | 0.57% | 0.39% | 3.74% |
| EPS (BASIC) | 7.59 | 5.47 | 3.78 | N.A. |
| P/E Pre IPO | 19.73 | |||
| P/E Post IPO | 14.58 |
Company Financial (In ₹Crore)
| Period Ended | Dec-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| Assets | 48.88 | 31.48 | 17.56 |
| Total Income | 48.97 | 49.15 | 17.43 |
| Profit After Tax | 6 | 4.33 | 2.96 |
| EBITDA | 8.99 | 6.53 | 4.43 |
| NET Worth | 19.54 | 13.53 | 9.2 |
| Reserves and Surplus | 11.63 | 5.62 | 1.29 |
| Total Borrowing | 14.92 | 7.69 | 3.58 |
Peer Comparison (Valuation)
| Company | P/E (x) | CMP*(₹) | Face value (₹) |
|---|---|---|---|
| Biopol Chemicals Limited | 19.73 | 108.00 | 10.00 |
| Rossari Biotech Limited | 20.93 | 515.50 | 2.00 |
| Fineotex Chemical Limited | 2.30 | 21.71 | 2.00 |
| Indian Emulsifiers Limited | 7.19 | 78.25 | 10.00 |
Peer Comparison (Financial Performance)
| Company | NAV/Share (₹) | RoNW (%) | EPS (Basic) (₹) |
|---|---|---|---|
| Biopol Chemicals Limited | 17.12 | 32.07 | 5.49 |
| Rossari Biotech Limited | 194.56 | 15.62 | 24.63 |
| Fineotex Chemical Limited | 54.93 | 19.31 | 9.44 |
| Indian Emulsifiers Limited | 91.04 | 20.01 | 10.88 |
About Company
Incorporated in 2023, Biopol Chemicals Limited is engaged in the manufacturing and distribution of specialty chemicals. The Company’s operations are focused on four key product categories: silicones, emulsifiers, biochemicals, and polyelectrolytes.
The Company operates on a B2B business model, supplying specialty chemical solutions primarily to institutional and industrial customers, and does not cater to retail end-users.
Product Portfolio
Biopol Chemicals offers a diversified portfolio of 66 specialty chemical products, comprising:
- 40 silicone-based products
- 5 emulsifier-based products
- 15 biochemical products
- 6 polyelectrolyte products
These products cater to multiple end-use industries, including textiles, home care, agriculture, and industrial chemicals.
Key Product Segments include:
- Textile Chemicals: Softeners, silicones, emulsions, hydrophilic finishes, hardeners & binders, dyeing and printing auxiliaries
- Home Care Chemicals: Silicone fluids, emulsifiers, cleaning chemicals
- Agriculture Chemicals: Silicone adjuvants, surfactants
- Industrial Chemicals: Silicone-based release agents and specialty lubricants for PVC
Manufacturing & Operations
The Company operates through four establishments located in Gujarat and West Bengal, which include:
- Manufacturing unit, corporate office, and warehouse in West Bengal
- Registered office in Gujarat
The manufacturing facility has an installed capacity of 18,25,000 litres per annum.
Strength
Integrated Manufacturing Facility: The Company operates a well-equipped manufacturing unit in West Bengal with an installed capacity of 18.25 lakh litres per annum, supported by reactors, mixers, homogenizers, and blending equipment, enabling efficient production of specialty chemicals.
Strong Quality & Compliance Standards: The manufacturing facility is certified under ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, with 42 products holding ZDHC Level 3 certification, reflecting high quality, environmental compliance, and safety standards.
Strategic Regional Presence: The Company has a strong revenue base in West Bengal and Gujarat, which together have consistently contributed a majority share of total revenues across recent financial periods, supporting operational stability and market access.
Weakness
Expansion & Execution Risk: The proposed expansion in Gujarat, including acquisition of industrial land and capacity enhancement, involves significant capital investment and is subject to regulatory approvals, construction, commissioning, and manpower risks. Any delay, cost overrun, or failure to achieve expected efficiencies may adversely impact operations and profitability.
Customer Concentration Risk: A substantial portion of the Company’s revenue is derived from a limited number of key customers, without long-term or repeat business agreements. Loss of, or reduced demand from, any major customer could materially affect revenue, cash flows, and financial performance.
Leased Premises Risk: All manufacturing, office, and warehouse facilities are operated from leased and unregistered premises. Any termination, non-renewal, rent escalation, or adverse change in lease terms could disrupt operations, increase costs, or require relocation, impacting business continuity.
Biopol Chemicals Lead Manager(s)
Biopol Chemicals Address
Biopol Chemicals Ltd. Address
D-211, 2nd Floor, Block-D,
Sumel Business Park-6 Near Dudheshwar Circle
Dudheshwar Tavdipura
Ahmedabad, Gujarat, 380004
Phnoe: +91- 9147076778
E-mail: investors@biopolchemicals.com
Website: https://biopolchemicals.com/